Scutellarin suppresses ovarian cancer progression by targeting METTL5.

Sci Rep · 2025 · PMC12117153 · PMID 40425707

Europe PMC DOI

hedged sentences

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendP = 0.09so close (0.05 < p ≤ 0.1)

In the univariate analysis, high METTL5 expression showed a trend towards poor prognosis (HR = 1.54, 95% CI 0.94–2.55, P = 0.09).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

While high METTL5 expression showed a trend toward poor prognosis in univariate analysis, it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.